Teva have deep pockets in the right circumstances and broad reach. they don't enter deals lightly so the partnership adds significant credibility to the product. Sets the scene nicely for other markets. Puts QRX on new radars as well. Massively undervalued at the moment IMO.
Add to My Watchlist
What is My Watchlist?